Insider · CIK 0001885321
Beth J. Hoffman
Files at BFRI (Biofrontera Inc.). First filing -, latest -.
In brief
Beth J. Hoffman files SEC Form 4 as director at BFRI (Biofrontera Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Beth J. Hoffman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | BFRI Biofrontera Inc. | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 6, 2026 |
| Jul 22, 2025 | BFRI Biofrontera Inc. | AGrant or award Employee stock option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Sep 16, 2025 |
Questions about Beth J. Hoffman
Answered from the filings on this page, as of the latest one.
Is Beth J. Hoffman buying or selling?
Beth J. Hoffman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Beth J. Hoffman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Beth J. Hoffman has 0.
Where does Beth J. Hoffman file Form 4?
Beth J. Hoffman has filed Form 4 at BFRI (Biofrontera Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.